| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A gene signature of primary tumor identifies metastasized seminoma
|
Port, Matthias
|
|
2011
|
29 |
6 |
p. 764-773
10 p.
|
artikel
|
| 2 |
A MicroRNA expression profile defining the invasive bladder tumor phenotype
|
Wszolek, Matthew F.
|
|
2011
|
29 |
6 |
p. 794-801.e1
7217 p.
|
artikel
|
| 3 |
An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib
|
Pwint, Thinn P.
|
|
2011
|
29 |
6 |
p. 821-824
4 p.
|
artikel
|
| 4 |
Antiproliferative and apoptosis inducing effects of indirubin-3′-monoxime in renal cell cancer cells
|
Perabo, Frank G.E.
|
|
2011
|
29 |
6 |
p. 815-820
6 p.
|
artikel
|
| 5 |
Argument in favor of performing partial nephrectomy for tumors greater than 7 cm: The metastatic prescription has already been written
|
Bratslavsky, Gennady
|
|
2011
|
29 |
6 |
p. 829-832
4 p.
|
artikel
|
| 6 |
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer
|
Sonpavde, Guru
|
|
2011
|
29 |
6 |
p. 682-689
8 p.
|
artikel
|
| 7 |
Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer
|
Jeske, Stephanie
|
|
2011
|
29 |
6 |
p. 676-681
6 p.
|
artikel
|
| 8 |
Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer
|
Li, Yingming
|
|
2011
|
29 |
6 |
p. 624-633
10 p.
|
artikel
|
| 9 |
Contents
|
|
|
2011
|
29 |
6 |
p. x-xiv
nvt p.
|
artikel
|
| 10 |
DNA repair gene polymorphisms and prostate cancer risk in South Australia—results of a pilot study
|
Dhillon, Varinderpal S.
|
|
2011
|
29 |
6 |
p. 641-646
6 p.
|
artikel
|
| 11 |
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
|
Raman, Jay D.
|
|
2011
|
29 |
6 |
p. 716-723
8 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2011
|
29 |
6 |
p. v-
1 p.
|
artikel
|
| 13 |
Evaluation of the influence of polymorphic variants CYP1A1*2B, CYP1B1*2, CYP3A4*1B, GSTM1*0, and GSTT1*0 in prostate cancer
|
Rodrigues, Iara S.
|
|
2011
|
29 |
6 |
p. 654-663
10 p.
|
artikel
|
| 14 |
Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation
|
Ku, Ja Hyeon
|
|
2011
|
29 |
6 |
p. 731-737
7 p.
|
artikel
|
| 15 |
Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: Long-term follow-up
|
Schlenker, Boris
|
|
2011
|
29 |
6 |
p. 788-793
6 p.
|
artikel
|
| 16 |
Highlights of the 2010 SUO Annual Meeting
|
Lerner, Seth P.
|
|
2011
|
29 |
6 |
p. 825-
1 p.
|
artikel
|
| 17 |
Impact of radiofrequency ablation on PBMC subpopulation in patients with renal cell carcinoma
|
Matuszewski, Marcin
|
|
2011
|
29 |
6 |
p. 724-730
7 p.
|
artikel
|
| 18 |
Improving the efficacy of targeted trials by multiple-marker analysis in castration-resistant prostate cancer
|
Ohlmann, Carsten-Henning
|
|
2011
|
29 |
6 |
p. 664-669
6 p.
|
artikel
|
| 19 |
Information for Authors
|
|
|
2011
|
29 |
6 |
p. IBC-
1 p.
|
artikel
|
| 20 |
Intermediate-differentiated invasive (pT1 G2) penile cancer—oncological outcome and follow-up
|
Schlenker, Boris
|
|
2011
|
29 |
6 |
p. 782-787
6 p.
|
artikel
|
| 21 |
Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor
|
Sadeghi, Neda
|
|
2011
|
29 |
6 |
p. 837-841
5 p.
|
artikel
|
| 22 |
Masthead
|
|
|
2011
|
29 |
6 |
p. iv-
1 p.
|
artikel
|
| 23 |
Molecular imaging of the small renal mass
|
Smaldone, Marc C.
|
|
2011
|
29 |
6 |
p. 589-592
4 p.
|
artikel
|
| 24 |
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial
|
Kim, William Y.
|
|
2011
|
29 |
6 |
p. 608-613
6 p.
|
artikel
|
| 25 |
Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: A single-center experience
|
Audenet, François
|
|
2011
|
29 |
6 |
p. 602-607
6 p.
|
artikel
|
| 26 |
Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models
|
Li, Yingming
|
|
2011
|
29 |
6 |
p. 802-808
7 p.
|
artikel
|
| 27 |
Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma
|
Ke, Hung-Lung
|
|
2011
|
29 |
6 |
p. 703-709
7 p.
|
artikel
|
| 28 |
Patterns of enlarged lymph nodes in patients with metastatic renal cell carcinoma
|
Hadley, David A.
|
|
2011
|
29 |
6 |
p. 751-755
5 p.
|
artikel
|
| 29 |
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
|
Lin, Jianqing
|
|
2011
|
29 |
6 |
p. 670-675
6 p.
|
artikel
|
| 30 |
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study
|
Bassi, Pier Francesco
|
|
2011
|
29 |
6 |
p. 698-702
5 p.
|
artikel
|
| 31 |
Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma
|
Elfiky, Aymen A.
|
|
2011
|
29 |
6 |
p. 756-763
8 p.
|
artikel
|
| 32 |
Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States
|
Gilbert, Scott M.
|
|
2011
|
29 |
6 |
p. 647-653
7 p.
|
artikel
|
| 33 |
Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer
|
Payne, Heather
|
|
2011
|
29 |
6 |
p. 593-601
9 p.
|
artikel
|
| 34 |
Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma
|
Boran, Cetin
|
|
2011
|
29 |
6 |
p. 614-623
10 p.
|
artikel
|
| 35 |
Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
|
Manassero, Francesca
|
|
2011
|
29 |
6 |
p. 745-750
6 p.
|
artikel
|
| 36 |
Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma
|
Asimakopoulos, Anastasios D.
|
|
2011
|
29 |
6 |
p. 690-697
8 p.
|
artikel
|
| 37 |
Squamous cell carcinoma of the penis: Predicting nodal metastases by histologic grade, pattern of invasion and clinical examination
|
Alkatout, Ibrahim
|
|
2011
|
29 |
6 |
p. 774-781
8 p.
|
artikel
|
| 38 |
Surgical therapy for intermediate risk prostate cancer
|
Schade, George R.
|
|
2011
|
29 |
6 |
p. 833-836
4 p.
|
artikel
|
| 39 |
Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma
|
Passerotti, Carlo C.
|
|
2011
|
29 |
6 |
p. 710-715
6 p.
|
artikel
|
| 40 |
The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation
|
Daneshmand, Siamak
|
|
2011
|
29 |
6 |
p. 842-847
6 p.
|
artikel
|
| 41 |
The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection
|
Katz, Matthew D.
|
|
2011
|
29 |
6 |
p. 738-744
7 p.
|
artikel
|
| 42 |
Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium
|
Botelho, Mónica C.
|
|
2011
|
29 |
6 |
p. 809-814
6 p.
|
artikel
|
| 43 |
Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci
|
Sciarra, Alessandro
|
|
2011
|
29 |
6 |
p. 634-640
7 p.
|
artikel
|
| 44 |
Warm ischemia less than 30 minutes is not necessarily safe during partial nephrectomy: Every minute matters
|
Patel, Amit R.
|
|
2011
|
29 |
6 |
p. 826-828
3 p.
|
artikel
|
Tijdschrift beschrijving